A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...

Regeneron’s lead counsel was Jonathan D. Polkes of White & Case LLP.

Key products like Prolia and Repatha saw strong sales growth, though Enbrel and Tepezza experienced declines. Amgen reaffirmed its full-year guidance and continues to focus on expanding its ...

Coming back to the first-quarter results, sales of most of its products, like Prolia, Xgeva, Repatha, Blincyto and Evenity, beat estimates. Fourteen products, including Repatha, Blincyto, Tezspire, ...

Nexletol and Repatha are both cholesterol-lowering medications. Repatha contains the active ingredient evolocumab. Nexletol’s active ingredient is bempedoic acid. Repatha works in a slightly ...

CNS disorders rake in more than $ 80 billion a year for the pharma industry, however higher failure rates in clinical trials are forcing big companies to cut down their spend on CNS drug R&D ...

Notable contributors included Repatha (evolocumab) for hypercholesterolemia and hyperlipidemia, Blincyto (blinatumomab) for B-cell acute lymphocytic leukaemia, recently approved in June 2024, and ...

Notable contributors included Repatha (evolocumab) for hypercholesterolemia and hyperlipidemia, Blincyto (blinatumomab) for B-cell acute lymphocytic leukaemia, recently approved in June 2024 ...

Background: There is sparse high-quality safety and effectiveness data for pulsed field ablation (PFA) of persistent atrial fibrillation (PerAF), where lesions beyond pulmonary vein isolation (PVI) ...

We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other ...